KRX •
Healthcare •
Biotechnology •
Quote as of 06/22/2026 10:17
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization64,353 mln
Float3.74 mln
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.04
Debt-free
Pre-Tax Margin
5%
Low margin
ROE
-1.14
Negative
Dividend Yield
0.54%
Low
DPS
38.42
Low
Business Description
Founded in 1973 and headquartered in Seoul, South Korea, Samik Pharmaceutical Company has spent decades creating and producing a wide range of medicines for patients. The company specializes in oral treatments and works to improve how drugs are delivered to the body, find new uses for existing medicines, and strengthen biological therapies.
